By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Identifying and developing novel treatments for rare diseases and diseases caused by multi-drug66.8M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States66.8M100.00%